Bleakley Financial Group LLC lifted its position in shares of Clover Health Investments, Corp. (NASDAQ:CLOV – Free Report) by 98.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,090 shares of the company’s stock after purchasing an additional 9,988 shares during the period. Bleakley Financial Group LLC’s holdings in Clover Health Investments were worth $57,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors also recently made changes to their positions in the company. Jupiter Asset Management Ltd. grew its position in Clover Health Investments by 18.1% during the first quarter. Jupiter Asset Management Ltd. now owns 4,525,079 shares of the company’s stock worth $3,593,000 after buying an additional 692,878 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of Clover Health Investments in the 2nd quarter valued at $932,000. AQR Capital Management LLC boosted its holdings in shares of Clover Health Investments by 4.6% in the 2nd quarter. AQR Capital Management LLC now owns 729,706 shares of the company’s stock valued at $898,000 after purchasing an additional 32,288 shares in the last quarter. Choreo LLC acquired a new stake in shares of Clover Health Investments in the 2nd quarter valued at $344,000. Finally, Bayesian Capital Management LP acquired a new stake in shares of Clover Health Investments in the 1st quarter valued at $142,000. Institutional investors own 19.77% of the company’s stock.
Clover Health Investments Stock Up 0.3 %
Shares of NASDAQ:CLOV opened at $3.79 on Friday. The firm has a market cap of $1.88 billion, a P/E ratio of -11.15 and a beta of 2.13. Clover Health Investments, Corp. has a 12-month low of $0.61 and a 12-month high of $4.71. The business has a fifty day simple moving average of $3.25 and a 200 day simple moving average of $1.90.
Wall Street Analysts Forecast Growth
Separately, UBS Group began coverage on Clover Health Investments in a report on Monday, October 7th. They issued a “neutral” rating and a $4.00 target price on the stock.
Get Our Latest Analysis on Clover Health Investments
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Recommended Stories
- Five stocks we like better than Clover Health Investments
- 3 Stocks to Consider Buying in October
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Dividend Payout Ratio Calculator
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- What Are Trending Stocks? Trending Stocks Explained
- Tesla Stock: Buy the Dips, Sell the Rips
Want to see what other hedge funds are holding CLOV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clover Health Investments, Corp. (NASDAQ:CLOV – Free Report).
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.